We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDER Planning Multiple Generics Guidances in 2021, Agenda Reveals
CDER Planning Multiple Generics Guidances in 2021, Agenda Reveals
The FDA’s Center for Drug Evaluation and Research (CDER) has released its list of planned new and revised guidances for calendar year 2021, an agenda that includes a large number of generic drug-related topics.